JP2022508835A5 - - Google Patents
Info
- Publication number
- JP2022508835A5 JP2022508835A5 JP2021546400A JP2021546400A JP2022508835A5 JP 2022508835 A5 JP2022508835 A5 JP 2022508835A5 JP 2021546400 A JP2021546400 A JP 2021546400A JP 2021546400 A JP2021546400 A JP 2021546400A JP 2022508835 A5 JP2022508835 A5 JP 2022508835A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862747089P | 2018-10-17 | 2018-10-17 | |
| US62/747,089 | 2018-10-17 | ||
| PCT/AU2019/051134 WO2020077412A1 (en) | 2018-10-17 | 2019-10-17 | Methods for treating oculopharyngeal muscular dystrophy (opmd) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022508835A JP2022508835A (ja) | 2022-01-19 |
| JPWO2020077412A5 JPWO2020077412A5 (https=) | 2022-10-24 |
| JP2022508835A5 true JP2022508835A5 (https=) | 2022-10-24 |
Family
ID=70282838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546400A Pending JP2022508835A (ja) | 2018-10-17 | 2019-10-17 | 眼咽頭筋ジストロフィー（ｏｐｍｄ）を治療するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220106594A1 (https=) |
| EP (1) | EP3866859A4 (https=) |
| JP (1) | JP2022508835A (https=) |
| KR (1) | KR20210081361A (https=) |
| CN (1) | CN112867511A (https=) |
| AU (1) | AU2019362925A1 (https=) |
| BR (1) | BR112021007256A2 (https=) |
| CA (1) | CA3114945A1 (https=) |
| IL (1) | IL282323A (https=) |
| MX (1) | MX2021004225A (https=) |
| SG (1) | SG11202102185RA (https=) |
| WO (1) | WO2020077412A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115838725B (zh) * | 2022-12-30 | 2023-09-08 | 广州派真生物技术有限公司 | 在哺乳动物心脏中特异性启动基因的启动子序列及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014117050A2 (en) * | 2013-01-26 | 2014-07-31 | Mirimus, Inc. | Modified mirna as a scaffold for shrna |
| CA3020754C (en) * | 2016-04-14 | 2023-07-25 | Benitec Biopharma Limited | Reagents for treatment of oculopharyngeal muscular dystrophy (opmd) and use thereof |
| EP3555294A4 (en) * | 2016-12-14 | 2020-08-26 | Benitec Biopharma Limited | REAGENTS FOR THE TREATMENT OF OCULOPHARYNGEAL MUSCLE DYSTROPHY (PDD) AND THEIR USE |
| US20220098614A1 (en) * | 2019-02-28 | 2022-03-31 | Benitec IP Holdings Inc. | Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD) |
-
2019
- 2019-10-17 CN CN201980066632.9A patent/CN112867511A/zh active Pending
- 2019-10-17 JP JP2021546400A patent/JP2022508835A/ja active Pending
- 2019-10-17 KR KR1020217014239A patent/KR20210081361A/ko not_active Withdrawn
- 2019-10-17 US US17/285,569 patent/US20220106594A1/en not_active Abandoned
- 2019-10-17 MX MX2021004225A patent/MX2021004225A/es unknown
- 2019-10-17 AU AU2019362925A patent/AU2019362925A1/en not_active Abandoned
- 2019-10-17 SG SG11202102185RA patent/SG11202102185RA/en unknown
- 2019-10-17 EP EP19872588.9A patent/EP3866859A4/en not_active Withdrawn
- 2019-10-17 CA CA3114945A patent/CA3114945A1/en active Pending
- 2019-10-17 WO PCT/AU2019/051134 patent/WO2020077412A1/en not_active Ceased
- 2019-10-17 BR BR112021007256-0A patent/BR112021007256A2/pt not_active IP Right Cessation
-
2021
- 2021-04-13 IL IL282323A patent/IL282323A/en unknown